Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron
Gerben M van Buul1, Gyula Kotek, Piotr A Wielopolski
1Department of Radiology, Erasmus MC, Rotterdam, The Netherlands.
Plos One
|March 5, 2011
Summary
Superparamagnetic iron oxides (SPIO) safely label human mesenchymal stem cells for tracking in cartilage repair. MRI can visualize and quantify these SPIO-labeled cells within joints, aiding therapy assessment.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cell Biology
Background:
- Articular cartilage regeneration is limited, driving interest in cell-based therapies.
- Effective cell tracking is crucial for understanding and optimizing cartilage repair strategies.
- Superparamagnetic iron oxides (SPIO) offer potential for labeling cells for imaging.
Purpose of the Study:
- To evaluate the efficacy and safety of SPIO labeling for human bone marrow-derived mesenchymal stem cells (hBMSCs).
- To assess the impact of SPIO labeling on hBMSC viability, metabolic activity, and differentiation.
- To investigate the intra-articular visualization and quantification of SPIO-labeled cells using MRI.
Main Methods:
- SPIO labeling of hBMSCs was performed, followed by various assays to assess efficacy and safety.
- Synovial cell uptake of SPIO from dead cells was studied in vitro.
- MRI traceability was evaluated in a joint model simulating intra-articular injection and cartilage defect implantation.
Main Results:
- SPIO labeling was effective and did not negatively affect hBMSC viability, metabolic activity, or secretion profiles.
- Synovial cells demonstrated the capacity to re-uptake SPIO from dead labeled cells.
- MRI successfully visualized and quantified SPIO-labeled cells in a clinically relevant joint model.
Conclusions:
- SPIO labeling is a safe method for hBMSCs, preserving cell behavior and function.
- SPIO-labeled cells are traceable via MRI within the intra-articular environment.
- MRI enables quantification of SPIO-labeled cells within cartilage defects, supporting cell therapy monitoring.


